4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-024390
COO and Secretary sold 7,500 shares at an average $28.05 ($210,396)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuth Alexander O. COO and Secretary | 2019-04-09 | Sale | −2,475 | $28.17 | $69,721 | 652,614 | I |
| Schuth Alexander O. COO and Secretary | 2019-04-10 | Sale | −2,513 | $28.26 | $71,017 | 650,101 | I |
| Schuth Alexander O. COO and Secretary | 2019-04-11 | Sale | −2,512 | $27.73 | $69,658 | 647,589 | I |
| Open-market sales · 7,500 sh · avg $28.05 · $210,396 | |||||||
Loading xslF345X03/doc4.xml…